81147-94-6 + 75-31-0 = 81161-17-3 反应条件:1.1 Solvents: Methanol; Reflux1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Methanol 标题:Hitting A Soft Drug With A Hard Nucleophile: Preparation Of Esmolol'S Metabolite By Treatment With Bis(Tributyltin) Oxide 作者:Zhang,Cunyu A.; Et Al 参考文献:Synthetic Communications 日期:2012 卷标:42(5) 页码:722-726]
501-97-3 = 81161-17-3 反应条件:1.1 -2.1 -3.1 -4.1 Reagents: Hydrochloric Acid 标题:Ultra-Short-Acting β-Adrenergic Receptor Blocking Agents. 2. (Aryloxy)Propanolamines Containing Esters On The Aryl Function 作者:Erhardt,Paul W.; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:1982 卷标:25(12) 页码:1408-12]
= 81161-17-3 反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol 标题:Synthesis Of Esmolol Hydrochloride 作者:Cao,Sheng-Li; Et Al 参考文献:Zhongguo Yiyao Gongye Zazhi 日期:2000 卷标:31(12) 页码:532-533]
81147-94-6 + 75-31-0 = 81161-17-3 反应条件:1.1 -2.1 Reagents: Hydrochloric Acid 标题:Ultra-Short-Acting β-Adrenergic Receptor Blocking Agents. 2. (Aryloxy)Propanolamines Containing Esters On The Aryl Function 作者:Erhardt,Paul W.; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:1982 卷标:25(12) 页码:1408-12]
81147-92-4 = 81161-17-3 反应条件:1.1 Reagents: Hydrochloric Acid 标题:Ultra-Short-Acting β-Adrenergic Receptor Blocking Agents. 2. (Aryloxy)Propanolamines Containing Esters On The Aryl Function 作者:Erhardt,Paul W.; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:1982 卷标:25(12) 页码:1408-12]
5597-50-2 = 81161-17-3 反应条件:1.1 Reagents: Potassium Carbonate Solvents: Acetone; Reflux2.1 Solvents: Methanol; Reflux2.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Methanol 标题:Hitting A Soft Drug With A Hard Nucleophile: Preparation Of Esmolol'S Metabolite By Treatment With Bis(Tributyltin) Oxide 作者:Zhang,Cunyu A.; Et Al 参考文献:Synthetic Communications 日期:2012 卷标:42(5) 页码:722-726]
5597-50-2 = 81161-17-3 反应条件:1.1 -2.1 -3.1 Reagents: Hydrochloric Acid 标题:Ultra-Short-Acting β-Adrenergic Receptor Blocking Agents. 2. (Aryloxy)Propanolamines Containing Esters On The Aryl Function 作者:Erhardt,Paul W.; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:1982 卷标:25(12) 页码:1408-12]
= 81161-17-3 反应条件:1.1 Reagents: Hydrochloric Acid2.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol 标题:Synthesis Of Esmolol Hydrochloride 作者:Cao,Sheng-Li; Et Al 参考文献:Zhongguo Yiyao Gongye Zazhi 日期:2000 卷标:31(12) 页码:532-533]
501-97-3 = 81161-17-3 反应条件:1.1 Acidified,Reflux2.1 Reagents: Potassium Carbonate Solvents: Acetone; Reflux3.1 Solvents: Methanol; Reflux3.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Methanol 标题:Hitting A Soft Drug With A Hard Nucleophile: Preparation Of Esmolol'S Metabolite By Treatment With Bis(Tributyltin) Oxide 作者:Zhang,Cunyu A.; Et Al 参考文献:Synthetic Communications 日期:2012 卷标:42(5) 页码:722-726
专利号:US-9757463-B2 优先权日:2012-06-15 标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures 发明人:HARTH EVA M; BEEZER DAIN B; LI GUANGZHAO; SPEARS BENJAMIN R; STEVENS DAVID M 权利人:UNIV VANDERBILT 摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
专利号:US-6030613-A 优先权日:1995-01-17 标题:Receptor specific transepithelial transport of therapeutics 发明人:BLUMBERG RICHARD S; SIMISTER NEIL E; LENCER WAYNE I 权利人:BRIGHAM & WOMENS HOSPITAL; UNIV BRANDEIS 摘要:The present invention relates in general to methods and products for initiating an immune response against an antigen, and in particular relates to transepithelial delivery of antigens to provoke tolerance and immunity. The present invention further relates to methods and products for the transepithelial delivery of therapeutics. In particular, the invention relates to methods and compositions for the delivery of therapeutics conjugated to a FcRn binding partner to intestinal epithelium, mucosal epithelium and epithelium of the lung. The present invention further relates to the synthesis, preparation and use of the FcRn binding partner conjugates as, or in, pharmaceutical compositions for oral systemic delivery of drugs and vaccines.
专利号:US-7547436-B2 优先权日:1995-01-17 标 题:Receptor specific transepithelial transport of therapeutics 发明人:BLUMBERG RICHARD S; LENCER WAYNE I; SIMISTER NEIL E 权利人:BRIGHAM & WOMENS HOSPITAL; UNIV BRANDEIS 摘要:The present invention relates in general to methods and products for initiating an immune response against an antigen, and in particular relates to transepithelial delivery of antigens to provoke tolerance and immunity. The present invention further relates to methods and products for the transepithelial delivery of therapeutics. In particular, the invention relates to methods and compositions for the delivery of therapeutics conjugated to a FcRn binding partner to intestinal epithelium, mucosal epithelium and epithelium of the lung. The present invention further relates to the synthesis, preparation and use of the FcRn binding partner conjugates as, or in, pharmaceutical compositions for oral systemic delivery of drugs and vaccines.
专利号:US-9745419-B2 优先权日:2014-01-24 标 题 :Aqueous polyglycidol synthesis with ultra-low branching 发明人:HARTH EVA M; SPEARS BENJAMIN R 权利人:UNIV VANDERBILT 摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for a variety of applications, including, but not limited to, drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
专利号:WO-2024097977-A1 优先权日:2022-11-04 标题:Silk nanoparticle synthesis: tuning size, dispersity, and surface chemistry for drug delivery 发明人:SHAIDANI SAWNAZ; FALCUCCI THOMAS; FOSTER OLIVIA; SAHOO JUGAL KISHORE; HASTURK ONUR; KAPLAN DAVID L; JACOBUS CHARLOTTE S 权利人:TUFTS COLLEGE 摘要:Methods disclosed herein relate to generating silk nanoparticles with a low polydispersity index (PDI). Methods include adding a silk solution dropwise into a volatile solvent that is miscible with water, thereby forming a precipitate-bearing solution and applying shear forces to the precipitate-bearing solution for a length of time sufficient to achieve evaporation of at least 95% of the volatile solvent, thereby producing a population of silk fibroin nanoparticles in water having a polydispersity index (PDI) of 0.35 or less, including but not limited to, a PDI of 0.330 or less, 0.325 or less, 0.315 or less, 0.310 or less, 0.30 or less, 0.275 or less, 0.250 or less, 0.225 or less, or 0.200 or less. Parameters related to silk fibroin molecular weight, silk fibroin concentration, shear force application, and temperature may all be modified to achieve silk nanoparticles of a particular size exhibiting particular PDIs.
专利号:US-2016206743-A1 优先权日:2012-06-15 标题 :Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures
1: Zhao B, Sun W. Incompatibility of esmolol hydrochloride and furosemide in a central venous access port. Am J Health Syst Pharm. 2014 Jun 1;71(11):901-2. doi: 10.2146/ajhp130526. Erratum in: Am J Hosp Pharm 1988 Jun;45(6):1281. Review.
合成参考文献
摘要:McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 2003. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2003 (Plus Supplements)., p. 1754